Koos de Wit

8PUBLICATIONS
34CO-AUTHORS
Disease surveillancePredictive and prognostic markersEthical use of new technologyNutritional epidemiologyReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 30, 2025
Rifaximin-α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization.

Diederick J van Doorn, Kirsi M A van Eekhout, Koos de Wit

|Oct 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.

Adrià Juanola, Ann Thu Ma, Koos de Wit

|Feb 28, 2023
Opt-In and Opt-Out Consent Procedures for the Reuse of Routinely Recorded Health Data in Scientific Research and Their Consequences for Consent Rate and Consent Bias: Systematic Review.

Yvonne de Man, Yvonne Wieland-Jorna, Bart Torensma

|Feb 10, 2023
Decompensation as initial presentation in patients with liver cirrhosis is associated with an increased risk of future decompensation and mortality.

Koos de Wit, Thijs Kuipers, Koen Van der Ploeg

|Dec 04, 2022
Rifaximin stimulates nitrogen detoxification by PXR-independent mechanisms in human small intestinal organoids.

Koos de Wit, Ulrich Beuers, Anna Mukha

|Dec 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.

Elisa Pose, Elsa Solà, Juan J Lozano

Pageof 2

Frequent Collaborators

3 joint publications

R Bart Takkenberg

2 joint publications

Jonel Trebicka

2 joint publications

Pere Ginès

2 joint publications

Salvatore Piano